Share on StockTwits
 

Centene Corp. (NYSE:CNC) was upgraded by stock analysts at Credit Suisse from a “neutral” rating to an “outperform” rating in a report issued on Thursday, TheFlyOnTheWall.com reports. The firm currently has a $70.00 price objective on the stock, down from their previous price objective of $72.00. Credit Suisse’s target price suggests a potential upside of 11.93% from the company’s current price.

Centene Corp. (NYSE:CNC) traded up 1.76% during mid-day trading on Thursday, hitting $62.54. 819,475 shares of the company’s stock traded hands. Centene Corp. has a 1-year low of $41.64 and a 1-year high of $67.84. The stock has a 50-day moving average of $58.8 and a 200-day moving average of $59.07. The company has a market cap of $3.425 billion and a P/E ratio of 29.09.

A number of other analysts have also recently weighed in on CNC. Analysts at Deutsche Bank reiterated a “hold” rating on shares of Centene Corp. in a research note to investors on Monday, December 16th. They now have a $67.00 price target on the stock, down previously from $71.00. Separately, analysts at Susquehanna upgraded shares of Centene Corp. from a “neutral” rating to a “positive” rating in a research note to investors on Monday, December 16th. They now have a $68.00 price target on the stock, up previously from $60.00. Finally, analysts at Zacks downgraded shares of Centene Corp. from an “outperform” rating to a “neutral” rating in a research note to investors on Thursday, November 21st. They now have a $68.90 price target on the stock. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and fourteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $69.31.

Centene Corporation is a multi-line healthcare enterprise, which provides programs and services to the number of under-insured and uninsured individuals.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.